Mesa Laboratories Inc
MLAB76.344USD
+1.434+1.91%
交易中 （美东）报价延迟15分钟
416.49M总市值
亏损市盈率 TTM
关于 Mesa Laboratories Inc 公司
Mesa Laboratories, Inc. 为制药、医疗保健和医疗器械行业的受监管应用设计和制造生命科学工具和关键质量控制解决方案。其部门包括灭菌和消毒控制、临床基因组学、生物制药开发和校准解决方案。灭菌和消毒控制部门制造和销售生物、化学和清洁指示剂。它还提供测试和实验室服务，主要面向牙科和制药行业。临床基因组学部门开发、制造和销售基因分析工具及相关消耗品和服务。生物制药开发部门开发、制造和销售用于蛋白质分析（免疫测定）和肽合成解决方案的自动化系统。校准解决方案部门开发、制造、销售和服务质量控制产品。它在美国和欧洲设有制造业务。
公司简介
公司代码MLAB
公司名称Mesa Laboratories Inc
上市日期Feb 29, 1984
CEOMr. Gary M. Owens
员工数量730
证券类型Ordinary Share
年结日Feb 29
公司地址12100 W 6th Ave
城市LAKEWOOD
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编80228
电话13039878000
网址https://mesalabs.com
公司代码MLAB
上市日期Feb 29, 1984
CEOMr. Gary M. Owens
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
136.70K
+10.89%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.66K
-0.63%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
136.70K
+10.89%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.66K
-0.63%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
41.70K
+31.03%
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Discrete Revenues- Consumables
138.73M
57.57%
Discrete Revenues- Hardware and Software
59.66M
24.76%
Contracted Revenues- Services
28.68M
11.90%
Discrete Revenues- Services
13.91M
5.77%
地区USD
名称
营收
占比
United States
116.61M
48.39%
Other
99.05M
41.10%
China
25.31M
10.50%
业务
地区
业务USD
名称
营收
占比
Discrete Revenues- Consumables
138.73M
57.57%
Discrete Revenues- Hardware and Software
59.66M
24.76%
Contracted Revenues- Services
28.68M
11.90%
Discrete Revenues- Services
13.91M
5.77%
股东统计
更新时间: 6月3日 周二
更新时间: 6月3日 周二
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.44%
Conestoga Capital Advisors, LLC
10.29%
The Vanguard Group, Inc.
6.97%
Royce Investment Partners
4.93%
Ranger Investment Management, L.P.
4.20%
Other
60.18%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.44%
Conestoga Capital Advisors, LLC
10.29%
The Vanguard Group, Inc.
6.97%
Royce Investment Partners
4.93%
Ranger Investment Management, L.P.
4.20%
Other
60.18%
股东类型
持股股东
占比
Investment Advisor
46.83%
Investment Advisor/Hedge Fund
42.48%
Individual Investor
5.12%
Research Firm
3.47%
Pension Fund
1.17%
Bank and Trust
1.16%
Hedge Fund
0.48%
Sovereign Wealth Fund
0.04%
Insurance Company
0.03%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
397
5.61M
101.98%
-506.98K
2025Q1
415
5.83M
106.86%
-307.02K
2024Q4
405
5.76M
105.94%
-86.00K
2024Q3
413
5.30M
97.90%
-538.92K
2024Q2
412
5.31M
98.26%
-376.30K
2024Q1
404
5.28M
97.81%
-366.78K
2023Q4
400
5.27M
97.82%
-295.14K
2023Q3
392
5.33M
99.02%
-178.63K
2023Q2
390
5.31M
98.92%
-355.72K
2023Q1
390
5.48M
102.56%
-202.35K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
739.18K
13.55%
-14.26K
-1.89%
Mar 31, 2025
Conestoga Capital Advisors, LLC
571.36K
10.47%
-1.68K
-0.29%
Mar 31, 2025
The Vanguard Group, Inc.
383.30K
7.03%
+1.76K
+0.46%
Mar 31, 2025
Royce Investment Partners
271.12K
4.97%
-16.09K
-5.60%
Mar 31, 2025
Ranger Investment Management, L.P.
230.99K
4.23%
-2.57K
-1.10%
Mar 31, 2025
State Street Global Advisors (US)
219.54K
4.02%
-5.36K
-2.38%
Mar 31, 2025
Geneva Capital Management LLC
189.31K
3.47%
+299.00
+0.16%
Mar 31, 2025
Eagle Asset Management, Inc.
187.02K
3.43%
+19.79K
+11.84%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
147.79K
2.71%
-22.00K
-12.96%
Mar 31, 2025
Glenmede Investment Management LP
146.54K
2.69%
-5.30K
-3.49%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.82%
Invesco S&P SmallCap Health Care ETF
0.37%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
WisdomTree US SmallCap Fund
0.08%
Fidelity Small-Mid Multifactor ETF
0.07%
WisdomTree U.S. SmallCap Dividend Fund
0.07%
SPDR S&P SmallCap 600 ESG ETF
0.06%
Vanguard US Multifactor ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
查看更多
Pacer US Small Cap Cash Cows Growth Leaders ETF
占比0.82%
Invesco S&P SmallCap Health Care ETF
占比0.37%
SPDR SSGA US Small Cap Low Volatility Index ETF
占比0.1%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.09%
WisdomTree US SmallCap Fund
占比0.08%
Fidelity Small-Mid Multifactor ETF
占比0.07%
WisdomTree U.S. SmallCap Dividend Fund
占比0.07%
SPDR S&P SmallCap 600 ESG ETF
占比0.06%
Vanguard US Multifactor ETF
占比0.06%
Avantis US Small Cap Equity ETF
占比0.06%
分红派息
近5年累计派现
16.82M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jan 08, 2025
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 17, 2025
Feb 28, 2025
Oct 02, 2024
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 16, 2024
Nov 29, 2024
Jul 10, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 16, 2024
Aug 30, 2024
Apr 05, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024
May 31, 2024
Jun 14, 2024
May 31, 2024
Jan 04, 2024
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024
Feb 29, 2024
Mar 15, 2024
Feb 28, 2024
Oct 03, 2023
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023
Nov 30, 2023
Dec 15, 2023
Nov 29, 2023
Jul 05, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023
Aug 31, 2023
Sep 15, 2023
Aug 30, 2023
Apr 04, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 15, 2023 going ex on May 30, 2023
May 31, 2023
Jun 15, 2023
May 30, 2023
Jan 04, 2023
MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Mar 15, 2023 going ex on Feb 27, 2023
Feb 28, 2023
Mar 15, 2023
Feb 27, 2023
Oct 04, 2022
MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Dec 15, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 15, 2022
Nov 29, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
